195 related articles for article (PubMed ID: 2808039)
1. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
[TBL] [Abstract][Full Text] [Related]
2. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer.
Alpert TE; Morbidini-Gaffney S; Chung CT; Bogart JA; Hahn SS; Hsu J; Kellman RM
Cancer J; 2004; 10(6):335-8. PubMed ID: 15701263
[TBL] [Abstract][Full Text] [Related]
4. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
[TBL] [Abstract][Full Text] [Related]
5. Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience.
Nakfoor BM; Spiro IJ; Wang CC; Martins P; Montgomery W; Fabian R
Head Neck; 1998 Aug; 20(5):379-84. PubMed ID: 9663664
[TBL] [Abstract][Full Text] [Related]
6. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
Head Neck; 1993; 15(2):87-96. PubMed ID: 8440619
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionation for head and neck cancer.
Parsons JT; Mendenhall WM; Cassisi NJ; Isaacs JH; Million RR
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):649-58. PubMed ID: 3350719
[TBL] [Abstract][Full Text] [Related]
8. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx.
Parsons JT; Mendenhall WM; Mancuso AA; Cassisi NJ; Stringer SP; Million RR
Head Neck; 1989; 11(2):123-8. PubMed ID: 2722488
[TBL] [Abstract][Full Text] [Related]
9. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy.
Howell-Burke D; Peters LJ; Goepfert H; Oswald MJ
Arch Otolaryngol Head Neck Surg; 1990 Jul; 116(7):830-5. PubMed ID: 2363922
[TBL] [Abstract][Full Text] [Related]
10. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
[TBL] [Abstract][Full Text] [Related]
11. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
12. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa.
Gwozdz JT; Morrison WH; Garden AS; Weber RS; Peters LJ; Ang KK
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):127-35. PubMed ID: 9300747
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
[TBL] [Abstract][Full Text] [Related]
14. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
15. Optimal treatment for the technically resectable squamous cell carcinoma of the supraglottic larynx.
Goepfert H; Jesse RH; Fletcher GH; Hamberger A
Laryngoscope; 1975 Jan; 85(1):14-32. PubMed ID: 1113591
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
17. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
Fein DA; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
[TBL] [Abstract][Full Text] [Related]
18. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
19. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
20. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.
Spriano G; Antognoni P; Sanguineti G; Sormani M; Richetti A; Ameli F; Piantanida R; Luraghi R; Magli A; Corvo R; Tordiglione M; Vitale V
Am J Otolaryngol; 2000; 21(1):14-21. PubMed ID: 10668672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
